A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity

NCT03032783 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic and Lymphoid Cell Neoplasm

Interventions

RADIATION: Total-Body Irradiation
PROCEDURE: Donor Lymphocyte Infusion
DRUG: Cyclophosphamide
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University